Chuck Miller, director of Solution Consulting, AspenTech, gives five important ways technology and automation can support pharma companies with mitigating increased complexity and seizing opportunities in the year ahead.
Since 2020, market disruption created by COVID-19 has primed every aspect of the pharma industry for change: something that they have been reluctant to do in the decades previous. Today, with more crises potentially awaiting around the corner, there is an openness across the pharmaceutical world to embrace new technologies with a sense of urgency.